RPG Life Sciences fixes record date July 9 for ₹24 dividend
RPG Life Sciences Limited has fixed July 9, 2026, as the record date for a final dividend of ₹24 per share, subject to shareholder approval at the AGM on July 23, 2026. The meeting will be held via video conferencing.

*this image is generated using AI for illustrative purposes only.
RPG Life Sciences Limited has fixed Thursday, July 9, 2026, as the record date to determine shareholder eligibility for a final dividend of ₹24 per share for the financial year ended March 31, 2026. The dividend, recommended by the Board at its meeting on April 29, 2026, is subject to approval by shareholders at the Nineteenth Annual General Meeting (AGM) scheduled for Thursday, July 23, 2026. The payment will be made within 30 days of the AGM to members whose names appear in the Register of Members or the depositories' records on the record date.
The company communicated this decision to the National Stock Exchange of India Limited and BSE Limited pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The AGM will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) at 3.00 p.m. (IST).
| Symbol/Script code | Type of security | Record date | Purpose |
|---|---|---|---|
| NSE: RPGLIFE BSE: 532983 |
Equity | Thursday, July 9, 2026 | Payment of final dividend of ₹24 (300%) per Equity share of ₹8 each for FY26, subject to approval at the AGM on July 23, 2026. |
Rajesh Shirambekar, Head – Legal & Company Secretary, signed the regulatory filing confirming the schedule. The company has requested the exchanges to take the information on record. The Notice of AGM, containing further relevant details, will be issued in due course.
Historical Stock Returns for RPG Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.53% | +19.35% | +34.94% | +21.99% | +13.16% | +527.48% |
What factors might influence shareholder approval of the ₹24 per share dividend at the upcoming AGM?
How will this significant dividend payout impact RPG Life Sciences' capital allocation strategy for FY27?
Could this high dividend yield signal a shift in the company's policy towards returning excess cash to investors?































